Wurcel Alysse G, Chen Daniel D, Chui Kenneth K H, Knox Tamsin A
Department of Geographic Medicine and Infectious Diseases, Tufts Medical Center, Boston,Massachusetts; and.
Department of Public Health and Community Medicine, Tufts University School of Medicine, Boston,Massachusetts.
Open Forum Infect Dis. 2017 May 16;4(2):ofx098. doi: 10.1093/ofid/ofx098. eCollection 2017 Spring.
There are several barriers to annual hepatitis C virus antibody (HCVAb) testing, including lack of provider knowledge of the changing HCV epidemic and provider underestimation of a patient's risk. We identified low rates of testing for HCVAb in people living with human immunodeficiency virus (HIV) in our outpatient HIV Infectious Diseases clinic, and we developed a quality improvement project to increase rates of HCVAb screening.
每年进行丙型肝炎病毒抗体(HCVAb)检测存在若干障碍,包括医疗服务提供者对不断变化的丙型肝炎流行情况缺乏了解,以及对患者风险估计不足。我们发现,在我们的门诊艾滋病毒传染病诊所中,艾滋病毒(HIV)感染者的HCVAb检测率较低,因此我们开展了一个质量改进项目,以提高HCVAb筛查率。